A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure-Reference-Cited by-同舟云学术

A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure

Published:2018-05-02 Issue:4 Volume:4 Page:267-273
ISSN:2058-5225
Container-title:European Heart Journal - Quality of Care and Clinical Outcomes
language:en
Short-container-title:

Author:

Nilsson Erik¹²,De Deco Pietro³,Trevisan Marco⁴,Bellocco Rino³⁴,Lindholm Bengt¹,Lund Lars H⁵,Coresh Josef⁶,Carrero Juan J⁴

Affiliation:

1. Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska Universitetssjukhuset Huddinge, Stockholm, Stockholm, Sweden

2. Department of Internal Medicine, School of Medical Sciences, Örebro University, Södra Grev Rosengatan, Örebro, Örebro, Sweden

3. Milano Biccoca University, Milan, Italy

4. Department of Medical Epidemiology and Biostatistics (MEB), Karolinska Institutet, Nobels väg 12A, Stockholm, Sweden

5. Department of Medicine, Karolinska Institutet, Karolinska Universitetssjukhuset, Solna, Stockholm, Stockholm, Sweden

6. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, W6508, Baltimore, MD, USA

Funder

Swedish Heart and Lung Foundation

Swedish Research Council

AstraZeneca

Stockholm County Council

Martin Rind’s and Westman’s Foundations

National Institute of Diabetes and Digestive and Kidney Diseases

US National Kidney Foundation

Karolinska Institutet

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

Link

http://academic.oup.com/ehjqcco/article-pdf/4/4/267/25948159/qcy019.pdf

Reference27 articles.

1. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;Ponikowski;Rev Esp Cardiol (Engl Ed),2016

2. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines;Yancy;Circulation,2013

3. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

4. The effect of spironolactone on morbidity and mortality in patients with severe heart failure;Pitt;N Engl J Med,1999

5. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC;McMurray;Eur Heart J,2012

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC;European Journal of Heart Failure;2024-05-22

2. Rethinking albuminuria as a marker to drive treatment in congestive heart failure;European Heart Journal;2022-11-12

3. Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal disease;Pharmacological Research;2022-08

4. Salivary potassium measured by genetically encoded potassium ion indicators as a surrogate for plasma potassium levels in hemodialysis patients—a proof-of-concept study;Nephrology Dialysis Transplantation;2022-06-14

5. Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology;European Journal of Heart Failure;2022-03-27